Literature DB >> 23810521

Subsequent malignancies after photon versus proton radiation therapy.

Justin E Bekelman, Timothy Schultheiss, Amy Berrington De Gonzalez.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23810521     DOI： 10.1016/j.ijrobp.2013.05.016

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  11 in total

1.  Radiogenomic Predictors of Adverse Effects following Charged Particle Therapy.

Authors:  Lindsay M Morton; Luisel Ricks-Santi; Catharine M L West; Barry S Rosenstein
Journal:  Int J Part Ther       Date:  2018-09-21

Review 2.  Promise and pitfalls of heavy-particle therapy.

Authors:  Timur Mitin; Anthony L Zietman
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

3.  Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.

Authors:  Grace L Smith; Patricia A Ganz; Justin E Bekelman; Steven J Chmura; James J Dignam; Jason A Efstathiou; Reshma Jagsi; Peter A Johnstone; Michael L Steinberg; Stephen B Williams; James B Yu; Anthony L Zietman; Ralph R Weichselbaum; Ya-Chen Tina Shih
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-11-08       Impact factor: 7.038

Review 4.  Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review.

Authors:  Lucie M Turcotte; Joseph P Neglia; Raoul C Reulen; Cecile M Ronckers; Flora E van Leeuwen; Lindsay M Morton; David C Hodgson; Yutaka Yasui; Kevin C Oeffinger; Tara O Henderson
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

5.  Low- and middle-income countries can reduce risks of subsequent neoplasms by referring pediatric craniospinal cases to centralized proton treatment centers.

Authors:  Phillip J Taddei; Nabil Khater; Bassem Youssef; Rebecca M Howell; Wassim Jalbout; Rui Zhang; Fady B Geara; Annelise Giebeler; Anita Mahajan; Dragan Mirkovic; Wayne D Newhauser
Journal:  Biomed Phys Eng Express       Date:  2018-02-07

6.  Lifetime increased cancer risk in mice following exposure to clinical proton beam-generated neutrons.

Authors:  Leo E Gerweck; Peigen Huang; Hsiao-Ming Lu; Harald Paganetti; Yenong Zhou
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-01       Impact factor: 7.038

Review 7.  National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.

Authors:  Daphne Haas-Kogan; Daniel Indelicato; Harald Paganetti; Natia Esiashvili; Anita Mahajan; Torunn Yock; Stella Flampouri; Shannon MacDonald; Maryam Fouladi; Kry Stephen; John Kalapurakal; Stephanie Terezakis; Hanne Kooy; David Grosshans; Mike Makrigiorgos; Kavita Mishra; Tina Young Poussaint; Kenneth Cohen; Thomas Fitzgerald; Vinai Gondi; Arthur Liu; Jeff Michalski; Dragan Mirkovic; Radhe Mohan; Stephanie Perkins; Kenneth Wong; Bhadrasain Vikram; Jeff Buchsbaum; Larry Kun
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-05-01       Impact factor: 7.038

8.  Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada?

Authors:  S Patel; X Kostaras; M Parliament; I A Olivotto; R Nordal; K Aronyk; N Hagen
Journal:  Curr Oncol       Date:  2014-10       Impact factor: 3.677

9.  Selection of external beam radiotherapy approaches for precise and accurate cancer treatment.

Authors:  Hiroki Shirato; Quynh-Thu Le; Keiji Kobashi; Anussara Prayongrat; Seishin Takao; Shinichi Shimizu; Amato Giaccia; Lei Xing; Kikuo Umegaki
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

10.  Postsurgical geometrical variations of tumor bed and brainstem during photon and proton therapy for pediatric tumors of the posterior fossa: dosimetric impact and predictive factors.

Authors:  Stefania Volpe; Pierre-Yves Bondiau; Line Claude; Audrey Claren; Laetitia Padovani; Hamza AlGhamdi; Gwenaëlle Duhil De Benaze; Lucas Opitz; Guillaume Baudin; Catherine Dejean; Daniel Maneval; Barbara Alicja Jereczek-Fossa; Jérôme Doyen
Journal:  Strahlenther Onkol       Date:  2021-08-05       Impact factor: 3.621
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.